Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
BRIEF-Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million Aug 10 (Reuters) - Jacobio Pharmaceuticals Group Co Ltd 1167.HK:
EXPECTS NET PROFIT OF NOT LESS THAN RMB600 MILLION FOR SIX MONTHS ENDED JUNE 30, 2026
SEES SIGNIFICANT GROWTH IN HY REVENUE
Further company coverage: 1167.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan